13G FILING FOR MFN AND CYCLERION - CREATED AND UPDATED ON 4.9.19

Company

Cyclerion Therapeutics, Inc.

Filed

April 11, 2019

Accession Number

0000904454-19-000355

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →